PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
14620930-0	2003	A newly developed angiotensin II type 1 receptor antagonist, CS866, promotes regression of cardiac hypertrophy by reducing integrin beta1 expression.	Olmesartan Medoxomil	61-66	angiotensin II receptor, type 1b	Rattus norvegicus	18-48	
11132603-3	2000	DESIGN: We studied the aortas of control rats and others receiving L-NAME or L-NAME plus an angiotensin II type 1 receptor antagonist (CS-866).	Olmesartan Medoxomil	135-141	angiotensin II receptor, type 1b	Rattus norvegicus	92-122	
12477969-4	2002	MATERIALS AND METHODS: In this study we compared the effects of CS-866, a new angiotensin II type 1 receptor antagonist, to that of an ACE inhibitor, temocapril hydrochloride, on the development and progression of diabetic nephropathy using Otsuka Long-Evans Tokushima fatty rats, a type II diabetes mellitus model animal.	Olmesartan Medoxomil	64-70	angiotensin II receptor, type 1b	Rattus norvegicus	78-108